<DOC>
	<DOCNO>NCT02301208</DOCNO>
	<brief_summary>This randomized Phase III study evaluate efficancy weekly cisplatin nedaplatin concurrent Intensity-modulated radiation therapy Nasopharyngeal Carcinoma ( NPC ) .</brief_summary>
	<brief_title>Weekly Cisplatin Nedaplatin Concurrent With Intensity-modulated Radiation Therapy Nasopharyngeal Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Nedaplatin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Pathologically confirm untreated NPC patient T12N13M0 T34NxM0 1870 year old MRI examination ECOG â‰¤ 2 With write consent With second cancer Pregnancy With severe disease ( blood , liver , kidney heart disease ) Could stag properly Without write consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>